Kristin Cederquist

Kristin Cederquist is a highly experienced scientist currently serving as Principal Scientist at DCN Dx since September 2017, where expertise in chemistry and chemical principles is applied to develop advanced point-of-care diagnostic tests with enhanced sensitivity. Prior to this role, Kristin held positions at IMRA America, Inc. and nanoRETE, Inc., focused on antibody-nanoparticle bioconjugates and tech transfer of cell-based assays, respectively. Earlier academic roles included a Postdoctoral Research Associate at the University of Toronto, where electrochemical nucleic acid assays were developed, and a Graduate Researcher at Penn State University, leading a project on pathogen DNA detection. Kristin's educational background includes a Ph.D. in Chemistry from Penn State University and a B.S. in Chemistry from Vanderbilt University.